Immunocore Holdings plc - American Depositary Shares — Balance Sheet (NASDAQ:IMCR) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets ———597 M1.01 B1.07 B Total liabilities ———228.16 M648.79 M686.24 M Total equity ———368.84 M360.72 M381.03 M Total liabilities & shareholders' equities ———597 M1.01 B1.07 B Total debt ———48.01 M391.01 M393.13 M Net debt ———-306.61 M-387.65 M-427.47 M

Immunocore Holdings plc - American Depositary Shares

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Haberler

Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma

Jefferies, rakip verisi öncesi Immunocore hissesi için Tut tavsiyesini korudu

Jefferies, gelir endişeleriyle Immunocore hissesini düşürdü

Jefferies downgrades Immunocore stock rating on revenue concerns

Immunocore Leerink Konferansı: Stratejik Büyüme ve İnovasyon

Immunocore at Leerink Conference: Strategic Growth and Innovation

Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25

Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript

Immunocore Holdings kazancı $0,40 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up